Surgical Debulking Before or After Chemotherapy: Stemming the Tide on Ovarian Cancer Recurrence

Publisher： Karger

E-ISSN： 2296-5262|33|6|286-287

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.6, 2010-05, pp. : 286-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

Intraperitoneal chemotherapy of ovarian cancer

By Lowe Thomas   Morgan Robert J  

Women's Health, Vol. 3, Iss. 4, 2007-07 ,pp. : 433-440

Future Medicine

Access to resources Recommend Favorite

Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study

By  

Oncology, Vol. 77, Iss. 6, 2010-02 ,pp. : 395-399

Karger

Access to resources Recommend Favorite

Breast Necrosis after Chemotherapy for Recurrent Ovarian Cancer: Report of a Case and Review of the Literature

By  

THE BREAST JOURNAL, Vol. 21, Iss. 4, 2015-07 ,pp. : 418-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 36, Iss. 6, 2013-05 ,pp. : 324-332

Karger

Access to resources Recommend Favorite